Literature DB >> 6317244

The mitochondrial adenine nucleotide translocator is an antigen in primary biliary cirrhosis.

H P Schultheiss, P Berg, M Klingenberg.   

Abstract

Circulating antibodies reacting specifically with the adenine nucleotide translocator from liver mitochondria were detected in sera from 12 patients with proven primary biliary cirrhosis (PBC) by a solid phase double antibody immunoradiometric assay (IRMA). Furthermore these antibodies were absorbed with the isolated adenine nucleotide translocator from liver mitochondria. None of the sera from 20 normal individuals, four patients with anti-mitochondrial positive pseudolupus syndrome (PLE) sera (M-3) and three patients with syphilis (anti-M-l) had antibodies directed against this protein from inner mitochondrial membrane. The adenine nucleotide translocator as antigen in PBC could clearly be distinguished from the ATPase associated PBC specific M-2 antigen. With the present study, for the first time, a well characterized protein from inner mitochondrial membrane has been clearly defined as an autoantigen in primary biliary cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6317244      PMCID: PMC1536148     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  A simple and rapid method for the preparation of adenosine triphosphatase from submitochondrial particles.

Authors:  R B Beechey; S A Hubbard; P E Linnett; A D Mitchell; E A Munn
Journal:  Biochem J       Date:  1975-06       Impact factor: 3.857

3.  Purification of the carboxy-atractylate binding protein from mitochondria.

Authors:  P Riccio; H Aquila; M Klingenberg
Journal:  FEBS Lett       Date:  1975-08-01       Impact factor: 4.124

4.  [Lupus erythematosus-like syndrome with antimitochondrial antibodies].

Authors:  D Maas; H Schubothe
Journal:  Dtsch Med Wochenschr       Date:  1973-01-26       Impact factor: 0.628

5.  Rapid micro-radioimmunoassay for the measurement of antiviral antibody.

Authors:  J D Rosenthal; K Hayashi; A L Notkins
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

6.  [Mitochondrial antibodies in nonhepatic diseases. Occurrence, significance and differential diagnosis].

Authors:  P A Berg; U Traunecker; A Märker
Journal:  Dtsch Med Wochenschr       Date:  1973-06-08       Impact factor: 0.628

7.  Analysis of parameters affecting the solid phase radioimmunoassay quantitation of antibody to meningococcal antigens.

Authors:  W D Zollinger; J M Dalrymple; M S Artenstein
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

8.  Mode of insulin action.

Authors:  A H Kissebah; B R Tulloch; H Hope-Gill; P V Clarke; N Vydelingum; T R Fraser
Journal:  Lancet       Date:  1975-01-18       Impact factor: 79.321

9.  Isolation of the ADP, ATP carrier as the carboxyatractylate . protein complex from mitochondria.

Authors:  M Klingenberg; P Riccio; H Aquila
Journal:  Biochim Biophys Acta       Date:  1978-08-08

10.  Mitochondrial antibodies in primary biliary cirrhosis. I. Localization of the antigen to mitochondrial membranes.

Authors:  P A Berg; D Doniach; I M Roitt
Journal:  J Exp Med       Date:  1967-08-01       Impact factor: 14.307

View more
  16 in total

Review 1.  Primary biliary cirrhosis: nature of autoantigens.

Authors:  M F Bassendine; S J Yeaman
Journal:  Springer Semin Immunopathol       Date:  1990

Review 2.  Autoantibodies in primary biliary cirrhosis.

Authors:  P A Berg; R Klein
Journal:  Springer Semin Immunopathol       Date:  1990

3.  Specificities and characteristics of mitochondrial protein antigens assessed by enzyme linked immunosorbent assay for anti-mitochondrial antibodies. Relationship to immunofluorescent and precipitating antibodies.

Authors:  R C Gupta
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

4.  Primary biliary cirrhosis: assessment of the quantitative importance of the adenine nucleotide translocator protein as a major mitochondrial antigen.

Authors:  I Mendel-Hartvig; A Frostell; B D Nelson
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

5.  Characterization of a new mitochondrial antigen-antibody system (M9/anti-M9) in patients with anti-M2 positive and anti-M2 negative primary biliary cirrhosis.

Authors:  R Klein; P A Berg
Journal:  Clin Exp Immunol       Date:  1988-10       Impact factor: 4.330

6.  Detection of anti-mitochondrial antibodies by ELISA and Western-blot techniques and identification by one and two-dimensional gel electrophoresis of M2 target antigens.

Authors:  G Dighiero; C Magnac; J de Saint Martin; N Abuaf
Journal:  Clin Exp Immunol       Date:  1987-12       Impact factor: 4.330

7.  Precipitating autoantibodies to mitochondrial proteins in progressive systemic sclerosis.

Authors:  R C Gupta; J R Seibold; M R Krishnan; J C Steigerwald
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

8.  Primary biliary cirrhosis: further biochemical and immunological characterization of mitochondrial antigens.

Authors:  I Mendel-Hartvig; B D Nelson; L Lööf; T H Tötterman
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

9.  IgG from patients with liver diseases inhibit mitochondrial respiration in permeabilized oxidative muscle cells: impaired function of intracellular energetic units?

Authors:  Lumme Kadaja; Kai E Kisand; Nadezhda Peet; Urmo Braun; Kaja Metsküla; Kaupo Teesalu; Riina Vibo; Kalle V Kisand; Raivo Uibo; Harald Jockusch; Enn K Seppet
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

10.  High prevalence of anti-mitochondrial antibodies among patients with some well-defined connective tissue diseases.

Authors:  S Mouritsen; E Demant; H Permin; A Wiik
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.